Neural Networks Identify Drug Mimics as Potential Antiaging Nutraceuticals

The antidiabetic drug metformin and the immunosuppressant rapamycin are both FDA-approved mTOR, or mechanistic target of rapamycin, inhibitors that multiple animal studies have shown may have anticancer and antiaging properties beyond their licensed clinical applications. However, the potential to use these drugs for off-label, prophylactic use to prolong a healthy lifespan is hampered by their side effects.An international research team has now applied deep-learning neural networks to identify